Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Maus Frères S.A. in public offer for Gant Company AB (publ)
Mandate

Vinge advises Maus Frères S.A. in public offer for Gant Company AB (publ)

December 12, 2007

Vinge is advising Maus Frères S.A. in connection with its announced public offer for Gant Company AB (publ). The offer, which comprises all shares in Gant, values Gant at approximately SEK 5.2 billion.

The Vinge team advising Maus Frères S.A. includes partners Jan Lombach and Jan Byström and associate Mattias Friberg. Partner Carl Wetter and associates Per Karlsson and Peter Alstergren are providing competition law advice, and tax lawyer Maria Schultzberg and associate Maria Doeser are providing tax advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026